Core Body Therapy

03/06/2026

Study Highlights the Real-World Impact of CranioSacral Therapy (CST)

A large prospective cohort study explored how CranioSacral Therapy is being used in real-world primary health care — and the findings are compelling.

✨ Safe and effective across all age groups — from infants to adults
✨ Significant improvements in pain, function, sleep, and emotional wellbeing
✨ No serious adverse events reported

This research reflects what many therapists witness daily in clinical practice: CST supports the body’s natural capacity for regulation, healing, and resilience.

If you are committed to integrative, patient-centered care, this study reinforces the meaningful work you do every day.

📖 Read the full article here:https://www.iahe.com/storage/docs/articles/The-use-and-benefits-of-Craniosacral-Therapy-in-primary-health-care_-A-prospective-cohort-study-_-Elsevier-Enhanced-Reader.pdf

02/22/2026

Migraines are often explained as a simple vascular problem.

Blood vessels dilate. Pain follows.

But that model is incomplete.

What drives many migraines is neurovascular inflammatory signaling — a coordinated interaction between nerves, immune mediators, and mitochondrial stress.

At the center of this process is the trigeminal nerve.

When activated, it releases CGRP — calcitonin gene-related peptide — a neuropeptide that increases vascular permeability, promotes inflammation, and amplifies pain transmission.

But CGRP release doesn’t happen randomly.

It is often triggered by mitochondrial stress inside neurons.

When mitochondria lose efficiency — from sleep disruption, metabolic instability, oxidative stress, or hormonal fluctuation — ATP production declines and reactive oxygen species increase.

That redox imbalance sensitizes trigeminal neurons.

Once sensitized, even minor triggers can initiate:

• CGRP release
• Neurogenic inflammation
• Mast cell activation
• Cytokine amplification
• Central sensitization

This is why migraines often correlate with:

• Insulin resistance
• Sleep disruption
• Hormonal shifts
• Chronic stress
• Gut inflammation

The blood vessel dilation is real.

But it’s downstream.

The initiating signal is inflammatory and metabolic.

This also explains why modern therapies now target CGRP signaling directly — because blocking vascular dilation alone does not address the upstream neural-immune cascade.

Resolution matters here.

When inflammatory tone stabilizes:

• Trigeminal sensitivity decreases
• CGRP release normalizes
• Mitochondrial efficiency improves
• Neural excitability lowers

What supports that shift?

• Stabilizing blood glucose
• Sleep optimization
• Magnesium to support neuronal excitability balance
• Omega-3 intake to support pro-resolving mediator production
• Riboflavin (B2) for mitochondrial support
• Stress regulation to reduce sympathetic overdrive

Migraines are not just a vessel problem.

They are a signaling problem.

And signaling can be recalibrated.

02/20/2026

A new study suggests humans can sense hidden objects without touching them, by detecting faint movements in sand. This unexpected form of “remote touch” challenges traditional ideas about how the sense of touch works.

02/11/2026

Stress and inflammation are key elements to the root cause of heart disease.
Craniosacral bodywork helps to ease stress and inflammation by releasing tension deep in the nervous system and helping to bring your body back into balance.
Take a moment this month to do something to help your heart and let your stress drift away on my table.

01/31/2026

👇

01/30/2026

My office will be closed in observance of the National Shutdown and General Strike on Friday, January 30th. We stand in solidarity with our community and with the victims of state violence in Los Angeles, Minneapolis, and across the country.

Appointments are available this weekend.

01/09/2026

🤧

01/07/2026

A new CDC study published in JAMA today, shows COVID is still killing a substantial number of Americans, with over 100K deaths annually between 2022-2024.

‘Although the Public Health Emergency ended, this study suggests it remains a major driver of mortality among older adults.’

Between 2022 and 2024, covid-19 killed roughly 100,000 Americans annually, new research by CDC scientists shows.

01/04/2026

https://jamanetwork.com/journals/jama/fullarticle/2843606

This Medical News article discusses new research indicating that children whose mothers had COVID-19 during pregnancy were more likely to be diagnosed with a neurodevelopmental disorder by age 3 years.

12/13/2025

📣 Evolving the Legacy of CranioSacral Therapy
We’re excited to share a new paper from Upledger’s Science Team:
“The CranioSacral Rhythm—From Clinical Observation to Pacemaker Theory.”

This article honors Dr. John E. Upledger’s original clinical observations while bringing forward new research that supports the CranioSacral Rhythm as a measurable physiological phenomenon—and explores the emerging Pacemaker Theory as a model for understanding its origins.

When you train directly with the source, you’re not just learning CST—you’re advancing with the leaders continuing to shape the field.

📖 Read the article:https://www.iahe.com/storage/docs/articles/6YW3M8CmwFMOl2LkJMg4u9721pASRUnv9qar9sqC.pdf or Upledger.com Research Article Database Tab

12/10/2025

BREAKING:

"Our findings redefine SARS-CoV-2 infection as a condition of long-lasting immune compromise."

Highlights
•
SARS-CoV-2 causes lasting immune dysregulation for over 20 months.
•
The impact of SARS-CoV-2 on lymphocytes was especially severe in patients with CVD.
•
Lymphocyte deficiency is related to long COVID pathogenesis.
•
Long-term immune dysregulation of long COVID demands tailored treatment.

- December 5, 2025

https://www.sciencedirect.com/science/article/pii/S1201971225005090

11/30/2025

"You are not a mess. You are not behind. You are not failing at life. You are in a country on fire:"

Read more 👉 https://elejrnl.com?p=4158835